XML 41 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Mar. 31, 2018     45,118        
Beginning Balance at Mar. 31, 2018 $ 404,064   $ 450 $ 782,764 $ (373,678)   $ (5,472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 80,487     80,487      
Share issuances related to stock-based compensation (in shares)     2,579        
Share issuances related to stock-based compensation 41,984   $ 25 41,959      
Repurchase of common stock (in shares)     (2,115)        
Repurchase of common stock (132,697)   $ (21) (17,303) (115,373)    
Net income (loss) 3,561       3,561    
Other comprehensive income (loss) (6,096)           (6,096)
Ending Balance (in shares) at Mar. 31, 2019     45,582        
Ending Balance at Mar. 31, 2019 $ 391,303   $ 454 887,907 (485,490)   (11,568)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member            
Stock-based compensation $ 65,888     65,888      
Share issuances related to business combinations 1,616     1,616      
Share issuances related to stock-based compensation (in shares)     2,131        
Share issuances related to stock-based compensation 37,795   $ 21 37,774      
Repurchase of common stock (in shares)     (1,702)        
Repurchase of common stock (77,198)   $ (17) (14,526) (62,655)    
Net income (loss) (5,645)       (5,645)    
Other comprehensive income (loss) (1,855)           (1,855)
Ending Balance (in shares) at Mar. 31, 2020     46,011        
Ending Balance at Mar. 31, 2020 411,904 $ (84) $ 458 978,659 (553,790) $ (84) (13,423)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 84,833     84,833      
Share issuances related to stock-based compensation (in shares)     2,115        
Share issuances related to stock-based compensation $ 20,521   $ 21 20,500      
Repurchase of common stock (in shares) (1,643)   (1,644)        
Repurchase of common stock $ (95,259)   $ (16) (14,297) (80,946)    
Net income (loss) (30,954)       (30,954)    
Other comprehensive income (loss) 3,073           3,073
Ending Balance (in shares) at Mar. 31, 2021     46,482        
Ending Balance at Mar. 31, 2021 $ 394,034   $ 463 $ 1,069,695 $ (665,774)   $ (10,350)